老年人群瓣膜性心脏病与长期生存:OxVALVE社区队列研究
OxVALVE队列筛查4009名>65岁社区人群,3511人有死亡随访数据(中位6.49年),361人(10.3%)死亡。调整分析显示轻度瓣膜性心脏病(患病率44.9%)及临床显著瓣膜病(5.2%)均与全因死亡无显著关联,而晚期主动脉硬化(2.25%)和晚期二尖瓣环钙化(1.31%)与死亡风险升高相关。
要点
- 轻度瓣膜性心脏病在老年人群中常见,但调整后未显示与全因死亡增加相关。
- 晚期主动脉硬化或二尖瓣环钙化与死亡风险升高相关,合并显著瓣膜病时风险最高。
- 临床显著瓣膜病与死亡率无显著关联,可能反映该队列中患病率较低。
核心结论
- 晚期主动脉硬化或二尖瓣环钙化与更差的生存相关,尤其在合并显著瓣膜性心脏病时,但在无其他瓣膜病时也相关。
- 老年轻度瓣膜性心脏病患者可对其预后感到安心。
- 显著瓣膜性心脏病与死亡率无关联可能反映该队列中其患病率相对较低。
研究设计与样本
- OxVALVE(牛津瓣膜性心脏病)人群队列研究,筛查4009名年龄>65岁的参与者以确定瓣膜性心脏病的 presence 和严重程度。
- 将数据与国家死亡登记系统链接,进行详细结局分析;死亡数据可获取于3511名参与者,中位随访6.49年。
主要发现
- 3511名参与者中361人(10.3%)死亡;大多数存在某种瓣膜异常(n=2645,70.2%)。
- 调整分析中,轻度瓣膜性心脏病(患病率44.9%)与全因死亡增加无显著关联(HR 1.20,95%CI 0.96至1.51)。
- 临床显著瓣膜性心脏病(中重度狭窄或反流,患病率5.2%)与全因死亡无显著关联(HR 1.47,95%CI 0.94至2.31)。
- 晚期主动脉硬化(患病率2.25%)与死亡风险增加相关(HR 2.05,95%CI 1.28至3.30)。
- 晚期二尖瓣环钙化(患病率1.31%)与死亡风险增加相关(HR 2.51,95%CI 1.41至4.49);合并临床显著瓣膜病与晚期主动脉硬化或二尖瓣环钙化者死亡风险最高(HR 4.38,95%CI 1.99至9.67)。
临床怎么用
- 对老年轻度瓣膜性心脏病患者,可告知其预后相对良好,避免过度干预。
- 关注晚期主动脉硬化或二尖瓣环钙化的存在,尤其合并显著瓣膜病时,可能提示死亡风险升高。
局限性
- 显著瓣膜性心脏病与死亡率无关联可能反映该队列中其患病率相对较低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Valvular heart disease (VHD) is present in half the population aged >65 years but is usually mild and of uncertain importance. We investigated the association between VHD and its phenotypes with all-cause and cause-specific mortality. METHODS: The OxVALVE (Oxford Valvular Heart Disease) population cohort study screened 4009 participants aged >65 years to establish the presence and severity of VHD. We linked data to a national mortality registry and undertook detailed outcome analysis. RESULTS: Mortality data were available for 3511 participants, of whom 361 (10.3%) died (median 6.49 years follow-up). Most had some form of valve abnormality (n=2645, 70.2%). In adjusted analyses, neither mild VHD (prevalence 44.9%) nor clinically significant VHD (moderate or severe stenosis or regurgitation; 5.2%) was associated with increased all-cause mortality (HR 1.20, 95% CI 0.96 to 1.51 and HR 1.47, 95% CI 0.94 to 2.31, respectively). Conversely, advanced aortic sclerosis (prevalence 2.25%) and advanced mitral annular calcification (MAC, 1.31%) were associated with an increased risk of death (HR 2.05, 95% CI 1.28 to 3.30 and HR 2.51, 95% CI 1.41 to 4.49, respectively). Mortality was highest for people with both clinically significant VHD and advanced aortic sclerosis or MAC (HR 4.38, 95% CI 1.99 to 9.67). CONCLUSIONS: Advanced aortic sclerosis or MAC is associated with a worse outcome, particularly for patients with significant VHD, but also in the absence of other VHD. Older patients with mild VHD can be reassured about their prognosis. The absence of an association between significant VHD and mortality may reflect its relatively low prevalence in our cohort.
引用
- Taylor CJ, Ordóñez-Mena JM, Jones NR, et al. Survival of people with valvular heart disease in a large, English community-based cohort study. Heart. 2021. PMID: 34031157. doi:10.1136/heartjnl-2020-318823
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。